ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE

ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE

Εμφάνιση άλλων εκδόσεων (1)

Evidence based medicine data on ability of antiplatelet, including dual antiplatelet, therapy to improve the life expectancy of patients with high risk of thrombotic complications, especially patients with acute myocardial infarction is presented in brief. The problem of choosing a drug and resistan...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	S. Yu. Martsevich, N. P. Kutishenko, M. L. Ginzburg, A. M. Malysheva, Yu. N. Polyanskaya
Μορφή:	Άρθρο
Γλώσσα:	Russian
Έκδοση:	ABV-press 2014-07-01
Σειρά:	Klinicist
Θέματα:	antiplatelet agents aspirin clopidogrel myocardial infarction drug resistance proton pump inhibitors
Διαθέσιμο Online:	https://klinitsist.abvpress.ru/Klin/article/view/125

Παρόμοια τεκμήρια

ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE
ανά: S. Yu. Martsevich, κ.ά.
Έκδοση: (2014-07-01)

UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE
ανά: S. Yu. Martsevich, κ.ά.
Έκδοση: (2015-12-01)

MODERN ANTIPLATELET THERAPY OF ISCHEMIC HEART DISEASE PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: DATA FROM EVIDENCE-BASED MEDICINE AND REAL PRACTICE
ανά: S. Yu. Martsevich, κ.ά.
Έκδοση: (2016-01-01)

Effects of thienopyridine class antiplatelets on bleeding outcomes following robot-assisted radical prostatectomy
ανά: Masashi Kubota, κ.ά.
Έκδοση: (2024-03-01)

Antiplatelet treatment patterns and outcomes of secondary stroke prevention in the United States
ανά: Ellen O'Brien, κ.ά.
Έκδοση: (2023-02-01)

Non-responsiveness to oral antiplatelet treatment
ανά: Rok Perme, κ.ά.
Έκδοση: (2006-10-01)

How to undertake procedures while on antiplatelet agents: a hematologist's view
ανά: Dawn Swan, κ.ά.
Έκδοση: (2024-08-01)

Clinical Impact of Single and Dual Antiplatelet Therapy Beyond 12 Months on Ischemic Risk in Patients With Acute Myocardial Infarction
ανά: Ji Woong Roh, κ.ά.
Έκδοση: (2021-11-01)

Antiplatelet resistance and thromboembolic complications in neurointerventional procedures
ανά: Thomas J Oxley, κ.ά.
Έκδοση: (2011-12-01)

Antiplatelet treatment and gastro-intestinal hemorrhage risk
ανά: D. V. Duplyakov
Έκδοση: (2005-08-01)

Antiplatelet Therapy in the Patient with Coronary Stent Undergoing Surgery and Dental Procedure
ανά: Noppadol Chamnarnphol
Έκδοση: (2011-04-01)

Real-world experience of clinical management with antiplatelet and lipid-lowering therapy in post acute coronary syndrome patients in Indian setting
ανά: M S Hiremath, κ.ά.
Έκδοση: (2021-01-01)

MONITORING OF THE EFFECTIVENESS OF ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE
ανά: N. F. Puchinian, κ.ά.
Έκδοση: (2017-03-01)

Impact of antiplatelet therapy on hemostatic plug formation in the setting of thrombocytopenia
ανά: Robert H. Lee, κ.ά.
Έκδοση: (2025-01-01)

Antiplatelet Therapy in Atherothrombotic Diseases: Similarities and Differences Across Guidelines
ανά: Georges Jourdi, κ.ά.
Έκδοση: (2022-04-01)

Clopidogrel Resistance in Patients With Stroke Recurrence Under Single or Dual Antiplatelet Treatment
ανά: Hyun Goo Kang, κ.ά.
Έκδοση: (2021-08-01)

Impact of Concomitant Use of Proton Pump Inhibitors and Clopidogrel on Recurrent Stroke and Myocardial Infarction
ανά: Yong Kang Lee, κ.ά.
Έκδοση: (2023-08-01)

THE MODERN ASPECTS OF CLOPIDOGREL USE
ανά: E. N. Dankovtseva, κ.ά.
Έκδοση: (2016-01-01)

Evaluation of bleeding following dental extraction in patients on long-term antiplatelet therapy: A clinical trial
ανά: K George Varghese, κ.ά.
Έκδοση: (2015-01-01)

The Effects of Dual Antiplatelet Therapy on the Occurrence of Recurrent Cardiovascular Events After Myocardial Infarction in Obese Patients
ανά: Borovyk K., κ.ά.
Έκδοση: (2019-04-01)

Persistent risk of vascular complications and efficacy of prolonged dual antiplatelet therapy after myocardial infarction
ανά: I. S. Yavelo
Έκδοση: (2022-01-01)

Proton Pump Inhibitor for Gastrointestinal Bleeding in Patients with Myocardial Infarction on Dual-Antiplatelet Therapy: A Nationwide Cohort Study
ανά: Minyoul Baik, κ.ά.
Έκδοση: (2024-06-01)

Efficacy and safety of antiplatelet drugs in patients with chronic kidney disease
ανά: İbrahim Yıldız, κ.ά.
Έκδοση: (2014-07-01)

THE EFFECTIVENESS OF CLOPIDOGREL AS AN ANTITHROMBOTIC COMPARED TO TICLOPIDINE AND ASPIRIN (META-ANALYSIS)
ανά: Titien Siwi Hartayu, κ.ά.
Έκδοση: (2017-05-01)

Comparison of the Degree of Gastric Mucosal Injury between Patients Who Are Receiving Dual Antiplatelet Therapy or Single Antiplatelet Therapy
ανά: Yuji Shimada, κ.ά.
Έκδοση: (2022-09-01)

Dual antiplatelet therapy is associated with high α-tubulin acetylation in circulating platelets from coronary artery disease patients
ανά: Valentine Robaux, κ.ά.
Έκδοση: (2023-12-01)

Dual Antiplatelet Therapy Regimens and Duration for Intracranial Stenting Procedures: Literature Review
ανά: Milda Paliulytė, κ.ά.
Έκδοση: (2023-11-01)

Single and dual antiplatelet therapy in elderly patients of medically managed myocardial infarction
ανά: Ting-Tse Lin, κ.ά.
Έκδοση: (2018-04-01)

Best duration of dual antiplatelet therapy after drug-eluting stent implantation: an updated network meta-analysis of randomized controlled trials
ανά: Mahmoud Barbarawi, κ.ά.
Έκδοση: (2019-01-01)

Use of antiplatelet agents in patients after myocardial infarction followed up in Moscow outpatient clinics. Results of a non-interventional prospective study
ανά: A. I. Sapina, κ.ά.
Έκδοση: (2024-04-01)

PHARMACOGENETIC BASES OF INDIVIDUAL SENSITIVITY AND PERSONALIZED ADMINISTRATION OF ANTIPLATELET THERAPY IN DIFFERENT ETHNIC GROUPS
ανά: B. I. Kantemirova, κ.ά.
Έκδοση: (2021-05-01)

Duration of Antiplatelet Therapy Following Transcatheter Aortic Valve Replacement: Systematic Review and Network Meta‐Analysis
ανά: Toshiki Kuno, κ.ά.
Έκδοση: (2021-05-01)

Antiplatelet combinations for prevention of atherothrombotic events
ανά: Anselmino M, κ.ά.
Έκδοση: (2011-01-01)

Antiplatelet drugs and gastrointestinal disorders: when and how effective are inhibitors of proton pump?
ανά: Oksana Mikhaylovna Drapkina, κ.ά.
Έκδοση: (2011-10-01)

Optimal antiplatelet therapy after revascularization of left subclavian artery during TEVAR
ανά: Mengxiao Shi, κ.ά.
Έκδοση: (2024-06-01)

Incidence of major adverse cardiovascular events with genotype test guided antiplatelet treatment strategy after percutaneous coronary intervention
ανά: S. Ramesh, κ.ά.
Έκδοση: (2020-11-01)

Efficacy and safety of concomitant use of proton pump inhibitors with aspirin-clopidogrel dual antiplatelet therapy in coronary heart disease: A systematic review and meta-analysis
ανά: Xiaofeng Luo, κ.ά.
Έκδοση: (2023-01-01)

DENTAL MANAGEMENT AND BLEEDING COMPLICATIONS OF PATIENTS ON LONG-TERM ORAL ANTIPLATELET THERAPY. REVIEW OF EXISTING STUDIES AND GUIDELINES.
ανά: Atanaska Dinkova, κ.ά.
Έκδοση: (2013-06-01)

Double antiplatelet therapy in patients with acute coronary syndrome
ανά: A. V. Rodionov, κ.ά.
Έκδοση: (2011-10-01)

СONCOMITANT ADMINISTRATION OF CLOPIDOGREL AND PROTON PUMP INHIBITORS: ARE THERE ANY OPEN QUESTIONS LEFT TODAY?
ανά: S. Yu. Martsevich, κ.ά.
Έκδοση: (2015-09-01)